Analysts on Wall Street project that CME Group (CME) will announce quarterly earnings of $3.25 per share in its forthcoming report, representing an increase of 16.1% year over year. Revenues are projected to reach $1.87 billion, increasing 13.9% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone an upward revision of 1.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific CME metrics that are commonly monitored and projected by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Revenues- Other' of $114.87 million. The estimate indicates a year-over-year change of +4%.
The consensus estimate for 'Revenues- Clearing and transaction fees- Energy' stands at $277.80 million. The estimate suggests a change of +28.4% year over year.
Analysts forecast 'Revenues- Clearing and transaction fees- Metals' to reach $130.46 million. The estimate indicates a change of +84% from the prior-year quarter.
It is projected by analysts that the 'Revenues- Clearing and transaction fees' will reach $1.53 billion. The estimate suggests a change of +14.7% year over year.
Analysts predict that the 'Revenues- Clearing and transaction fees- Interest rates' will reach $496.56 million. The estimate points to a change of +13.8% from the year-ago quarter.
Based on the collective assessment of analysts, 'Average daily volume' should arrive at 34.56 million. Compared to the present estimate, the company reported 29.77 million in the same quarter last year.
The consensus among analysts is that 'Average daily volume- Metals' will reach 1.76 million. The estimate is in contrast to the year-ago figure of 732.00 thousand.
The combined assessment of analysts suggests that 'Average daily volume- Interest rates' will likely reach 17.50 million. Compared to the current estimate, the company reported 15.03 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Average daily volume- Equity indexes' should come in at 8.37 million. The estimate compares to the year-ago value of 8.00 million.
The average prediction of analysts places 'Average daily volume- Foreign exchange' at 1.14 million. Compared to the current estimate, the company reported 1.15 million in the same quarter of the previous year.
Analysts expect 'Average daily volume- Energy' to come in at 3.84 million. Compared to the current estimate, the company reported 2.90 million in the same quarter of the previous year.
Analysts' assessment points toward 'Average daily volume- Agricultural commodities' reaching 1.95 million. The estimate compares to the year-ago value of 1.96 million.
View all Key Company Metrics for CME here>>>Over the past month, CME shares have recorded returns of -4.7% versus the Zacks S&P 500 composite's +5.2% change. Based on its Zacks Rank #3 (Hold), CME will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
#1 Semiconductor Stock to Buy (Not NVDA)
The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.
One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.
See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CME Group Inc. (CME): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).